Correlation Between Mydecine Innovations and Easton Pharmaceutica

Can any of the company-specific risk be diversified away by investing in both Mydecine Innovations and Easton Pharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mydecine Innovations and Easton Pharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mydecine Innovations Group and Easton Pharmaceutica, you can compare the effects of market volatilities on Mydecine Innovations and Easton Pharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mydecine Innovations with a short position of Easton Pharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mydecine Innovations and Easton Pharmaceutica.

Diversification Opportunities for Mydecine Innovations and Easton Pharmaceutica

0.0

Correlation Coefficient

Mydecine Innovations  Easton Pharmaceutica

Pay attention - limited upside

The 3 months correlation between Mydecine and Easton is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Mydecine Innovations Group and Easton Pharmaceutica in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Easton Pharmaceutica and Mydecine Innovations is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mydecine Innovations Group are associated (or correlated) with Easton Pharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Easton Pharmaceutica has no effect on the direction of Mydecine Innovations i.e., Mydecine Innovations and Easton Pharmaceutica go up and down completely randomly.

Pair Corralation between Mydecine Innovations and Easton Pharmaceutica

If you would invest  0.60  in Mydecine Innovations Group on September 19, 2024 and sell it today you would earn a total of  0.00  from holding Mydecine Innovations Group or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Mydecine Innovations Group  vs.  Easton Pharmaceutica

Mydecine Innovations

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Mydecine Innovations Group are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Mydecine Innovations reported solid returns over the last few months and may actually be approaching a breakup point.

Easton Pharmaceutica

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Easton Pharmaceutica has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Easton Pharmaceutica is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Mydecine Innovations and Easton Pharmaceutica

The main advantage of trading using opposite Mydecine Innovations and Easton Pharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mydecine Innovations position performs unexpectedly, Easton Pharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Easton Pharmaceutica will offset losses from the drop in Easton Pharmaceutica's long position.

The idea behind Mydecine Innovations Group and Easton Pharmaceutica pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.